Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation ESC 2025

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Presenter: Martine Gilard

August 30, 2025

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation TCT 2024

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

Presenter: Daniel Overduin

October 30, 2024

Presentation TCT 2024

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

Presenter: Dirk Jan van Ginkel

October 29, 2024

Presentation TCT 2024

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Presenter: Wilbert Bor

October 27, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Presenter: Ting-Yu Wang

October 25, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Presenter: Claudio Cigalini

September 18, 2022

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

April 18, 2019

Advertisement

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Continuation versus Interruption of Oral Anticoagulation during TAVI

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Oral Anticoagulation Should Be the Default Strategy After LAAC

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content